Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of <i>Helicobacter pylori</i> Infection: A Randomized, Double-Blind, Phase III, Clinical TrialYoon Jin Choi, Jae Young Jang, Jeong Seop Moon et al.|Gut and Liver|2022Cited by 86
The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled StudyByung‐Wook Kim, Hyuk Soon Choi, Jong‐Jae Park et al.|Gut and Liver|2024Cited by 7